The number of inclusion-forming units (IFUs) observed in quantitative chlamydial cultures may be a surrogate for infectivity or transmissibility. Therefore, we conducted a cross-sectional study of 11,034 patients with Chlamydia trachomatis infection who presented to the SeattleKing County public health department clinics between 1988 and 1996, to determine relationships between the number of IFUs observed in culture and sex, age, race, and serovar class. Of the 11,034 cases of infection we studied, 6801 (62%) were cervical infections in women, and 4233 (38%) were urethral infections in men. The median count was 450 IFU for women and 72 IFU for men ( ). Overall, both men and women infected with B-class serovars P ! .001 had significantly higher IFU counts than did those infected with C-class serovars ( Despite recent reductions in prevalence in some parts of the United States, Chlamydia trachomatis remains the most commonly reported sexually transmitted pathogen in the country and produces serious morbidity and long-term sequelae, especially in women. Unfortunately, this group also has the highest prevalence of C. trachomatis infection [1] . Elucidation of the factors associated with the increased prevalence of chlamydial infections in young women may suggest new approaches to prevention. Although behavioral factors, such as age at first sexual intercourse, frequency of partner change, and failure to use barrier contraception, clearly are important in contributing to the increased prevalence of chlamydial infections in younger women [1] , the number of chlamydial inclusion-forming units (IFUs) in culture also has been shown to be higher in younger women [2, 3] . Because the number of IFUs observed in quantitative cell culture provides a measure of the number of viable, infectious elementary bodies in genital secretions, this number might be regarded as a surrogate for infectivity or transmissibility. Thus, factors associated with an increased IFU count also may be associated with heightened transmission. We have accumulated a large patient database over many years; we used standardized methods of specimen collection, transport, and culture and have utilized this database to examine the association of factors of interest with quantitative chlamydial culture results in multiple regression analyses.
Despite recent reductions in prevalence in some parts of the United States, Chlamydia trachomatis remains the most commonly reported sexually transmitted pathogen in the country and produces serious morbidity and long-term sequelae, especially in women. Unfortunately, this group also has the highest prevalence of C. trachomatis infection [1] . Elucidation of the factors associated with the increased prevalence of chlamydial infections in young women may suggest new approaches to prevention. Although behavioral factors, such as age at first sexual intercourse, frequency of partner change, and failure to use barrier contraception, clearly are important in contributing to the increased prevalence of chlamydial infections in younger women [1] , the number of chlamydial inclusion-forming units (IFUs) in culture also has been shown to be higher in younger women [2, 3] . Because the number of IFUs observed in quantitative cell culture provides a measure of the number of viable, infectious elementary bodies in genital secretions, this number might be regarded as a surrogate for infectivity or transmissibility. Thus, factors associated with an increased IFU count also may be associated with heightened transmission. We have accumulated a large patient database over many years; we used standardized methods of specimen collection, transport, and culture and have utilized this database to examine the association of factors of interest with quantitative chlamydial culture results in multiple regression analyses.
Methods
Patient population. The study population of 11,440 people consisted of 7096 women and 4344 men who had an episode of C. trachomatis genital infection that was culture-documented at any of the Seattle-King County Health Department sexually transmitted disease (STD) clinics during a 9-year period (1988) (1989) (1990) (1991) (1992) (1993) (1994) (1995) (1996) . Age, IFU data, or both was missing for 295 women and 111 men, which left 11,034 clinical isolates with complete data available for analyses. Every patient was evaluated; the examining clinician used a standardized interview sheet, and each patient received a physical examination. Recurrent episodes of infection were excluded from the analysis.
Specimen collection and isolation of C. trachomatis. The specimen collection and culture isolation techniques we utilized have been described in detail elsewhere [2] . Briefly, urethral specimens in men were collected with small Dacron swabs inserted 1-2 cm into the urethra (Hardwood, Guilford, ME), and cervical specimens were collected with a larger Dacron swab after the cervix was cleaned with a cotton pledget. Swabs were stored in 1500-mL transport media at 4ЊC and transported within 24 h to the laboratory. Each specimen was inoculated onto cycloheximide-treated McCoy cells, and chlamydial inclusions were detected with a genus-specific fluorescein-conjugated monoclonal antibody. Specimens that produced inclusions were stored at Ϫ70ЊC for serotyping.
Serotyping. A low-passage microtiter plate culture method was used for rapid immunotyping with a panel of 17 subspecies-and serovar-specific monoclonal antibodies on mature fixed inclusions, as described in detail elsewhere [2, 4] . Monoclonal antibodies were run individually or in non-cross-reactive pools to prevent ambiguous cross-reactivity. The wells then were reacted with a fluorescein isothiocyanate (FITC) conjugate (Sigma, St. Louis, MO) and read with an epifluorescence microscope. The final reaction patterns were compared with prototype strain reactions to determine serotype.
Quantitation of IFUs. Inclusions were identified visually and quantitated with genus-specific FITC labeled anti-chlamydial lipopolysaccharide monoclonal antibody (Washington Research Foundation, Seattle, WA), to identify wells positive for C. trachomatis. Fluorescence was observed with a Zeiss epifluorescence microscope to illuminate inclusions. The average inclusion count per 100-mL well was calculated by enumerating 3 fields and multiplying the average count by a predetermined conversion factor on the basis of the strength of magnification used to calculate number of inclusions per well in a standard manner. Cultures with !100 inclusions present were individually counted. We defined "100% infectivity" as all visualized cells' being infected. All technicians who determined IFU count followed the same standardized method.
Data collection and statistical analysis. Each patient's age, sex, race, and culture site were provided on the laboratory requisition forms that accompanied the cultures. These data were entered into the laboratory computer database, as were the culture results (including IFU count) and serotyping results as they were completed. Univariate comparisons were made on the basis of the Pearson's x 2 statistic for categorical variables and of the Student's t statistic for continuous variables. Because IFU counts were not normally distributed, we log-transformed the IFU counts (base 10), and nonparametric Wilcoxon rank tests were done to compare IFU counts. Multiple logistic regression analysis was used for multiple analysis of sex, race, age, and serovar class with IFU count. Because serovars may shift with time, the year of infection was included in the multiple regression model.
Results
Of the 11,034 cases of C. trachomatis, 6801 (62%) were cervical infections in women, and 4233 (38%) were urethral infections in men. The median count was 450 IFU for women and 72 IFU for men (table 1; ). Additionally, for each P ! .001 serovar type, the median IFU count was significantly higher for women than for men ( ). In women, serovars B, D, P ! .001 and E had the highest median counts (610, 540, and 540 IFU, respectively), and serovars J and D Ϫ had the lowest median count (270 and 170 IFU, respectively). Among men, serovars E and D had the highest median counts (95 and 80 IFU). Serovar types I and J were among the lowest (41 and 32 IFU) in men, although only 12 men had type I infections. Overall, infections with C-class serovars had significantly lower IFU counts (median, 350 IFU for women and 46 IFU for men) than did those with B-class serovars (median, 520 IFU for women and 85 IFU for men; for women and men). P ! .001 As noted above, the overall median count for women was significantly higher (450 IFU) than that for men (72 IFU; ), and this was also true within each age strata ( P ! .001 P ! ; figure 1). It was also striking that the median IFU count .001 decreased significantly among both women and men as age increased. The median IFU count for women was 625 for those !16 years old versus 185 for women у30 years old ( ). P ! .001 Similarly, for men, the median count was 210 IFU for those !16 years old versus 40.5 IFU for those у30 years old (P ! ). .001 (10) 18 (11) 166 (8) 112 (9) 14 (10) 19 (10) 3 (16) 62 (9) 84 (11) 28 (11) 18 (10) (6) 10 (6) 119 (5) 75 (6) 9 (4) 9 (5) 1 (5) 45 (7) 51 (6) 22 (9) 9 (5) 100% infected 694 (10.2) 10 (11) 89 (10) 10 (6) 322 (15) 129 (11) 16 (11) 16 (8) 0 (0) 35 (5) 28 (4) 27 (11) (7) 84 (14) 12 (12) 222 (17) 130 (16) 19 (16) 10 (9) 3 (25) 38 (10) 34 (7) 20 (11) Differences in IFU by racial or ethnic background also were examined (table 2). The median count was 475, 400, and 300 IFU for white, African American, and Native American women, respectively, and 85, 50, and 26 IFU for men within each group, respectively. When Asian patients were stratified into Southeast Asian and other Asian women and men, Southeast Asian subjects had lower median IFU counts than did other Asians ( ). However, Asian men had the highest P ! .001 median IFU count, and Asian women had IFU counts lower than those of white and African American women. The group "other or mixed" had high median IFU counts for both men and women. Table 3 presents the multiple regression coefficients (log IFU count) for factors associated with log IFU counts in a multiple regression model. A coefficient of 1.0 represents a 1 log difference in IFU (for example, from 10 to 100, or 100 to 1000). A positive coefficient, when used to calculate the median IFU count, represents a count higher than that of the reference group listed in each category, whereas a negative coefficient represents an IFU count lower than the reference. With respect to sex, women have a higher IFU count than does the reference (men), after we adjusted for all other factors in the table and for year of infection (coefficient 0.65;
). Similarly, when we ad-P ! .001 justed for all other variables in the model, age also remained highly related to IFU count, with decreasing IFU counts observed with increasing age. Finally, with respect to race, Native Americans had the lowest IFU count relative to whites (coefficient Ϫ0.23; ), with African Americans also having P ! .001 significantly lower counts than did whites (coefficient Ϫ0.12;
). Chlamydial infections of C-class serovars had a sig-P ! .001 nificantly lower IFU count than did those with B-class serovars, even after we adjusted for other variables. Thus, on average, in those subjects for whom racial background was known, C. trachomatis IFU counts are highest in young white women infected with B-class serovars.
Discussion
Quantitation of the number of virions in genital secretions recently has provided insights into the biology of HIV infection [5] . In this study, we have taken a similar approach with quantitative cultures of C. trachomatis urethral and cervical infections. It is important to note, however, that a wide variety of methodological factors affect the final number of IFUs observed in C. trachomatis culture. These include the technique and method of specimen collection, the rapidity of transport, the temperature and nature of the transport medium, the inoculum tested, the cell culture used, whether or not the cell culture was pretreated in any way, and the methodology used for staining and reading the plates microscopically. Although these variables can never be completely constant, we have utilized a standardized and uniform approach to C. trachomatis culture in our laboratory and clinic for many years. To the extent possible, we controlled for the above-noted variables in that uniform approaches to specimen collection and transport were utilized and that cultures were done by the same people during the period of study. In addition, we collected data about a large number of individually cultured patients, to minimize random variation and to facilitate multiple analysis. To simplify the analysis, we also excluded recurrent infections.
As in other reports, and consistent with most laboratories' unpublished experience, the mean IFUs were much higher in women (assessed by cervical swabs) than in men (assessed by urethral swabs). This may, in part, represent an artifact of specimen collection in that urethral swabs from men are smaller than those used for cervical specimens and probably collect 196 (8) 155 (9) 28 (9) 19 (15) 46 (8) 53 (10) 18 (6) 155 (7) 94 (6) 13 (4) 1 (1) 36 (6) 27 (5) 24 (8) 100% infected 239 (10) 112 (7) 18 (6) 10 (8) 48 (9) 31 (6) fewer secretions. In addition, the painful nature of urethral swab insertion in men encourages a briefer and more-superficial collection procedure, whereas access to the cervix during a speculum examination facilitates a longer swab insertion and a more-extensive sampling technique; during this procedure, the cervix can be seen clearly. However, the differences in IFU between men and women are highly consistent and quite striking (∼6-fold difference) and, thus, may reflect more-important biological differences, such as exposure to estrogenic hormones or the presence of a greater amount of susceptible epithelium, in women, or the chlamydia-killing effects of prostatic secretions or the flushing effect of urination, in men. The more common occurrence of both persistence of C. trachomatis infection in the lower genital tract and infection of upper genital tract tissues in women, as compared with men, may relate to the greater ability of the organism to proliferate, as reflected by higher IFUs, in the cervix, as compared with the urethra. The results we found by use of multiple regression analysis confirm previous reports that relate younger age to higher IFU count in both men and women [2, 3] . The larger number of patients studied in this analysis allows evaluation of age gradations and demonstrates a striking trend of falling mean IFU counts as age increases. As previously speculated, these agerelated changes in IFU may relate to acquisition of acquired immunity to chlamydia with increasing age, but actual evidence of this is lacking for either C. trachomatis or C. pneumoniae infection (which could induce protective cross-reactive antibodies). Analysis of these data strongly supports current approaches to C. trachomatis screening that focuses on adolescents, because these patients may be both the most infectious (i.e., able to transmit) and at the greatest risk for complications.
Another analysis that utilized an early subset of this data demonstrated that whites had higher IFUs than did African Americans [2] . The data set is now large enough to allow further evaluation of these and other racial groups by multiple analysis.
The current analysis shows that Native American men and women both had significantly lower IFU count than did whites. The same was also true for African Americans, although to a lesser degree. Because most epidemiological studies have demonstrated an increased prevalence of C. trachomatis in African Americans and Native Americans, we anticipated that median IFUs would be higher in these groups, which was the opposite of what we observed. Undoubtedly, differences among IFUs among racial groups are complex, and interactions of behavioral and biological factors are difficult to define specifically. Behavioral factors might include, for example, the effects of spermicide exposure or douching on the IFU count, which may vary in prevalence by race. Differences in health care-seeking behavior by racial groups may also contribute to racial differences in IFU count, because patients who present in an earlier stage of infection may have higher IFU counts. Similarly, patients who present as a contact to C. trachomatis may have lower IFU counts than do those who present because of symptoms of acute infection. Our data set does not allow evaluation of these factors because the reason for the visit and data regarding delay in seeking health care or exposure to spermicides or douching are not available.
Potential genetic differences in the immunological response to C. trachomatis infection related to race or ethnicity could also account for differences in IFU count by racial or ethnic group. Thus, specific genetically defined groups may be more likely to develop sequelae from C. trachomatis infections. HLA class I antigens A28 (allelic subtype A*6802) and A31 have been shown to be associated with ocular and genital sequelae, respectively, after C. trachomatis infection [6, 7] . Additionally, polymorphisms in the promoter region of the tumor necrosis factor-a gene have been more common among cases of scarring trachoma than among controls [8] . Finally, the amount of interferon-g in cervical secretions, a measure of Th1 response, differed in African American, as compared with white, women in one study [9] . It is, thus, likely that a complex relationship exists between race, the immune response, and IFU count.
In this cross-sectional study, the presence or absence of symptoms was not recorded. Whether IFU count is related to clinical signs and symptoms of chlamydial infections or to the presence or absence of complications is not known. Men have significantly lower IFU counts do than women, yet women are thought to be more often asymptomatic [10] . Reports of the relationship of serovar type to symptoms have conflicted in other reports. One study found no relationship between pelvic inflammatory disease and serovar types in women [2] , whereas another study found that women infected with serovars F and G were more likely to have abdominal pain [11] . Of interest, both of these studies found that women with serovars F and G had fewer cervical signs of infection [2, 11] . Studies that related serovar type to symptoms in men showed that men with F/G serovar infections had fewer polymorphonuclear leukocytes on Gram stain from urethral swabs than did men infected with other serovars [11, 12] . These results are consistent with our current data that show that people infected with intermediate-class serovars had lower IFU counts than did people infected with B-class serovars.
In conclusion, we have evaluated the association of quantitative C. trachomatis cultures with sex, age, race, and serovar in a multiple analysis involving 110,000 patients studied for a 9-year period. Because the distribution of serovars may shift with time, we controlled for year of infection in the multiple regression model. The large sample size and multiple analysis strengthen the validity of the results. Importantly, we studied patients attending STD clinics, and the results should not be generalized to other populations. Analysis of our data indicates that the numbers of IFUs were higher in the most prevalent class, B-class serovars, compared to the less prevalent class, Cclass serovars. In addition, the age group with the highest prevalence, adolescents, also had strikingly higher mean IFUs. Further studies of how the local and systemic immune responses influence behavioral factors, genetic factors, and length of infection of C. trachomatis IFUs would be of interest.
